JP XV Ultraviolet-visible Reference Spectra 1569
Droperidol
A solution prepared as follows: Dissolve 0.03 g in 10 mL of 0.1 mol/L hydrochloric acid TS and ethanol (95) to make 100 mL (in a brown volumetric flask). To 5 mL of this solution add 10 mL of 0.1 mol/L hydrochloric acid TS and ethanol (95) to make 100 mL (in a brown volumetric flask).
Dydrogesterone
A solution in methanol (1 in 200,000)
Edrophonium Chloride
Asolutionin0.1mol/LhydrochloricacidTS(1in20,000) 1570 Ultraviolet-visible Reference Spectra JP XV
Elcatonin
A solution prepared as follows: Dissolve 5 mg in 5 mL of water.
Enoxacin Hydrate
A solution prepared as follows: To 1 mL of a solution in dilute sodium hydroxide TS (1 in 2000) add water to make 100 mL.
Enviomycin Sulfate
An aqueous solution (1 in 100,000) JP XV Ultraviolet-visible Reference Spectra 1571
Eperisone Hydrochloride
A solution in methanol (1 in 100,000)
Ephedrine Hydrochloride
An aqueous solution (1 in 2000)
Epirizole
Asolutionin0.1mol/LhydrochloricacidTS(1in200,000) 1572 Ultraviolet-visible Reference Spectra JP XV
Epirubicin Hydrochloride
A solution in methanol (3 in 200,000)
Estazolam
Asolutionin1mol/LhydrochloricacidTS(1in100,000)
Estriol
A solution prepared as follows: Dissolve 0.01 mg in 100 mL of ethanol (95) (warming) JP XV Ultraviolet-visible Reference Spectra 1573
Etacrynic Acid
A solution in methanol (1 in 20,000)
Ethionamide
A solution in methanol (3 in 160,000)
Ethosuximide
A solution in ethanol (95) (1 in 2000) 1574 Ultraviolet-visible Reference Spectra JP XV
Ethyl Icosapentate
To 20 mg add 3 mL of a solution of potassium hydroxide in ethylene glycol (21 in 100), stopper tightly after passing ofNitrogen,heatat1809C for 15 minutes, and add methanol to make 100 mL after cooling. To 4 mL of this solu- tion add methanol to make 100 mL. Blank: A solution obtained by proceeding in the same manner with 3 mL of the solution of potassium hydroxide in ethylene glycol (21 in 100).
Ethylmorphine Hydrochloride Hydrate
An aqueous solution (1 in 10,000)
Etilefrine Hydrochloride
A solution prepared as follows: Dissolve 5 mg in 100 mL of diluted hydrochloric acid (1 in 1000) JP XV Ultraviolet-visible Reference Spectra 1575
Etizolam
A solution in ethanol (99.5) (1 in 100,000)
Etodolac
A solution in ethanol (99.5) (3 in 200,000)
Etoposide
A solution in methanol (1 in 10,000) 1576 Ultraviolet-visible Reference Spectra JP XV
Famotidine
A solution in 0.05 mol/L potassium dihydrogen phosphate TS (1 in 50,000)
Fenbufen
A solution in ethanol (95) (1 in 200,000)
Fentanyl Citrate
A solution prepared as follows: Dissolve 0.05 g in 10 mL of 0.1 mol/L hydrochloric acid TS and ethanol (95) to make 100 mL. JP XV Ultraviolet-visible Reference Spectra 1577
Flavoxate Hydrochloride
A solution in 0.01 mol/L hydrochloric acid TS (1 in 50,000)
Flomoxef Sodium
An aqueous solution (3 in 100,000)
Flopropione
A solution in ethanol (99.5) (1 in 200,000) 1578 Ultraviolet-visible Reference Spectra JP XV
Flucytosine
Asolutionin0.1mol/LhydrochloricacidTS(1in125,000)
Fludiazepam 1
A solution in methanol (1 in 200,000)
Fludiazepam 2
A solution in methanol (1 in 20,000) JP XV Ultraviolet-visible Reference Spectra 1579
Flunitrazepam
A solution in ethanol (99.5) (1 in 100,000)
Fluocinonide
A solution in methanol (1 in 100,000)
Fluorometholone
A solution in methanol (1 in 100,000) 1580 Ultraviolet-visible Reference Spectra JP XV
Fluorouracil
Asolutionin0.1mol/LhydrochloricacidTS(1in100,000)
Fluoxymesterone
A solution in ethanol (95) (1 in 100,000)
Fluphenazine Enanthate
A solution prepared as follows: Dissolve 2 mg in 200 mL of a solution of hydrochloric acid in methanol (17 in 2000). JP XV Ultraviolet-visible Reference Spectra 1581
Flurazepam 1
A solution in methanol (1 in 100,000)
Flurazepam 2
A solution in methanol (1 in 10,000)
Flurazepam Hydrochloride
A solution in sulfuric acid-ethanol TS (1 in 100,000) 1582 Ultraviolet-visible Reference Spectra JP XV
Flurbiprofen
A solution in methanol (1 in 200,000)
Folic Acid
A solution in dilute sodium hydroxide TS (3 in 200,000)
Formoterol Fumarate Hydrate
A solution in methanol (1 in 40,000) JP XV Ultraviolet-visible Reference Spectra 1583
Furosemide
A solution in dilute sodium hydroxide TS (1 in 125,000)
Gabexate Mesilate
An aqueous solution (1 in 100,000)
b-Galactosidase (Aspergillus)
A solution prepared as follows: Dissolve 0.1 mg in 100 mL of water (Filter if necessary.). 1584 Ultraviolet-visible Reference Spectra JP XV
Glibenclamide
A solution in methanol (1 in 10,000)
Gonadorelin Acetate
A solution in methanol (1 in 10,000)
Gramicidin
A solution in ethanol (95) (1 in 20,000) JP XV Ultraviolet-visible Reference Spectra 1585
Griseofulvin
A solution in ethanol (95) (1 in 100,000)
Guaifenesin
An aqueous solution (1 in 50,000)
Guanabenz Acetate
A solution in methanol (1 in 100,000) 1586 Ultraviolet-visible Reference Spectra JP XV
Haloperidol
A solution prepared as follows: Dissolve 30 mg in 100 mL of 2-propanol. To 5 mL of this solution add 10 mL of 0.1 mol/L hydrochloric acid TS and 2-propanol to make 100 mL.
Haloxazolam
A solution in methanol (1 in 100,000)
Homochlorcyclizine Hydrochloride
Asolutionin0.1mol/LhydrochloricacidTS(1in100,000) JP XV Ultraviolet-visible Reference Spectra 1587
Hydralazine Hydrochloride
An aqueous solution (1 in 100,000)
Hydrochlorothiazide
A solution prepared as follows: Dissolve 12 mg in 100 mL of sodium hydroxide TS. 10 mL of this solution add water to make 100 mL.
Hydrocotarnine Hydrochloride Hydrate
An aqueous solution (1 in 10,000) 1588 Ultraviolet-visible Reference Spectra JP XV
Hydroxocobalamin Acetate
A solution in acetic acid-sodium acetate buffer solution, pH 4.5 (1 in 50,000)
Hydroxyzine Hydrochloride
A solution in methanol (1 in 100,000)
Hydroxyzine Pamoate
A solution prepared as follows: Evaporate 2 mL of the sample solution obtained in the Identification (1) on a water bath to dryness, and dissolve the residue in 0.1 mol/L hydrochloric acid TS to make 500 mL. JP XV Ultraviolet-visible Reference Spectra 1589
Hymecromone
A solution in ethanol (99.5) (1 in 250,000)
Ibuprofen
A solution in dilute sodium hydroxide TS (3 in 20,000)
Idarubicin Hydrochloride
A solution in methanol (1 in 100,000) 1590 Ultraviolet-visible Reference Spectra JP XV
Idoxuridine
A solution in 0.01 mol/L sodium hydroxide TS (1 in 25,000)
Ifenprodil Tartrate
A solution in methanol (1 in 100,000)
Imipenem Hydrate
A solution in 0.1 mol/L 3-(N-morpholino)propanesulfonic acid buffer solution, pH 7.0 (1 in 50,000) JP XV Ultraviolet-visible Reference Spectra 1591
Imipramine Hydrochloride
A solution prepared as follows: Dissolve 5 mg in 250 mL of 0.01 mol/L hydrochloric acid TS
Indenolol Hydrochloride 1
An aqueous solution (1 in 50,000)
Indenolol Hydrochloride 2
An aqueous solution (1 in 10,000) 1592 Ultraviolet-visible Reference Spectra JP XV
Indigocarmine
A solution prepared as follows: Dissolve 0.1 g in 100 mL of an aqueous solution of ammonium acetate (1 in 650). To 1 mL of this solution add the aqueous solution of ammonium acetate (1 in 650) to make 100 mL.
Indometacin
A solution prepared as follows: Dissolve 2 mg in 200 mL of methanol.
Ipratropium Bromide Hydrate
A solution in 0.01 mol/L hydrochloric acid TS (3 in 2000) JP XV Ultraviolet-visible Reference Spectra 1593
Isoniazid
A solution prepared as follows: To 5 mL of an aqueous solution (1 in 10,000) add 1 mL of 0.1 mol/L hydrochloric acid TS and water to make 50 mL.
l-Isoprenaline Hydrochloride
Asolutionin0.1mol/LhydrochloricacidTS(1in20,000)
Josamycin
A solution in methanol (1 in 100,000) 1594 Ultraviolet-visible Reference Spectra JP XV
Josamycin Propionate
A solution in methanol (1 in 100,000)
Ketamine Hydrochloride
Asolutionin0.1mol/LhydrochloricacidTS(1in3000)
Ketoprofen
A solution in methanol (1 in 200,000) JP XV Ultraviolet-visible Reference Spectra 1595
Ketotifen Fumarate
A solution in methanol (1 in 50,000)
Kitasamycin
A solution in methanol (1 in 40,000)
Kitasamycin Acetate
A solution in methanol (1 in 40,000) 1596 Ultraviolet-visible Reference Spectra JP XV
Kitasamycin Tartrate
A solution in methanol (1 in 40,000)
Latamoxef Sodium
An aqueous solution (3 in 100,000)
Levallorphan Tartrate
A solution in 0.01 mol/L hydrochloric acid TS (1 in 10,000) JP XV Ultraviolet-visible Reference Spectra 1597
Levodopa
A solution in 0.001 mol/L hydrochloric acid TS (3 in 100,000)
Levothyroxine Sodium Hydrate
A solution in dilute sodium hydroxide TS (1 in 10,000)
Lidocaine
A solution prepared as follows: Dissolve 0.04 g in 10 mL of 1 mol/L hydrochloric acid TS and water to make 100 mL. 1598 Ultraviolet-visible Reference Spectra JP XV
Limaprost Alfadex
A solution prepared as follows: To 10 mL of a solution in dilute ethanol (3 in 10,000) add 1 mL of potassium hydroxide-ethanol TS, and allow to stand for 15 minutes.
Liothyronine Sodium
A solution in ethanol (95) (1 in 10,000)
Lisinopril Hydrate
A solution in methanol (1 in 1000) JP XV Ultraviolet-visible Reference Spectra 1599
Lorazepam
A solution in ethanol (95) (1 in 200,000)
Loxoprofen Sodium Hydrate
An aqueous solution (1 in 55,000)
Lysozyme Hydrochloride
A solution in acetate buffer solution, pH 5.4 (1 in 10,000) 1600 Ultraviolet-visible Reference Spectra JP XV
Maprotiline Hydrochloride
A solution in methanol (1 in 10,000)
Meclofenoxate Hydrochloride
An aqueous solution (1 in 10,000)
Mecobalamin 1
A solution in hydrochloric acid-potassium chloride buffer solution, pH 2.0 (1 in 20,000) JP XV Ultraviolet-visible Reference Spectra 1601
Mecobalamin 2
A solution in phosphate buffer solution, pH 7.0 (1 in 20,000)
Medazepam
A solution in methanol (1 in 100,000)
Mefenamic Acid
A solution prepared as follows: Dissolve 7 mg in a solution of hydrochloric acid in methanol (1 in 1000) to make 500 mL. 1602 Ultraviolet-visible Reference Spectra JP XV
Mefloquine Hydrochloride
A solution in methanol (1 in 25,000)
Mefruside
A solution in methanol (1 in 40,000)
Melphalan
A solution in methanol (1 in 10,000) JP XV Ultraviolet-visible Reference Spectra 1603
Mepenzolate Bromide
A solution in 0.01 mol/L hydrochloric acid TS (1 in 2000)
Mepivacaine Hydrochloride
An aqueous solution (1 in 2500)
Mequitazine
A solution in ethanol (95) (1 in 250,000) 1604 Ultraviolet-visible Reference Spectra JP XV
Mercaptopurine Hydrate
Asolutionin0.1mol/LhydrochloricacidTS(1in200,000)
Mestranol
A solution in ethanol (99.5) (1 in 10,000)
Metformin Hydrochloride
An aqueous solution (1 in 100,000) JP XV Ultraviolet-visible Reference Spectra 1605
Methotrexate
A solution prepared as follows: Dissolve 1 mg in 100 mL of 0.1 mol/L hydrochloric acid TS.
Methoxsalen
A solution in ethanol (95) (1 in 200,000)
Methyldopa Hydrate
Asolutionin0.1mol/LhydrochloricacidTS(1in25,000) 1606 Ultraviolet-visible Reference Spectra JP XV
dl-Methylephedrine Hydrochloride
An aqueous solution (1 in 2000)
Methylergometrine Maleate
The colored solution obtained in the Assay
Methylprednisolone
A solution in methanol (1 in 100,000) JP XV Ultraviolet-visible Reference Spectra 1607
Methylprednisolone Succinate
A solution in methanol (1 in 50,000)
Methyltestosterone
A solution in ethanol (95) (1 in 100,000)
Meticrane
A solution in methanol (3 in 10,000) 1608 Ultraviolet-visible Reference Spectra JP XV
Metildigoxin
A solution in methanol (1 in 50,000)
Metoclopramide
A solution prepared as follows: Dissolve 0.1 g in 1 mL of 1 mol/L hydrochloric acid TS, and add water to make 100 mL. To 1 mL of this solution add water to make 100 mL.
Metoprolol Tartrate
A solution in ethanol (95) (1 in 10,000) JP XV Ultraviolet-visible Reference Spectra 1609
Metronidazole
Asolutionin0.1mol/LhydrochloricacidTS(1in100,000)
Metyrapone
Asolutionin0.5mol/LsulfuricacidTS(1in100,000)
Mexiletine Hydrochloride
A solution in 0.01 mol/L hydrochloric acid TS (1 in 2000) 1610 Ultraviolet-visible Reference Spectra JP XV
Miconazole
A solution in methanol (1 in 2500)
Miconazole Nitrate
A solution in methanol (1 in 2500)
Midecamycin
A solution in methanol (1 in 50,000) JP XV Ultraviolet-visible Reference Spectra 1611
Midecamycin Acetate
A solution in methanol (1 in 50,000)
Minocycline Hydrochloride
A solution in a solution of hydrochloric acid in methanol (19 in 20,000) (1 in 62,500)
Mitomycin C
An aqueous solution (1 in 100,000) 1612 Ultraviolet-visible Reference Spectra JP XV
Morphine Hydrochloride Hydrate 1
An aqueous solution (1 in 10,000)
Morphine Hydrochloride Hydrate 2
A solution in dilute sodium hydroxide TS (1 in 10,000)
Nadolol
A solution in methanol (1 in 5000) JP XV Ultraviolet-visible Reference Spectra 1613
Nalidixic Acid
A solution in 0.01 mol/L sodium hydroxide TS (1 in 200,000)
Naloxone Hydrochloride
An aqueous solution (1 in 10,000)
Naproxen
A solution in ethanol (99.5) (1 in 50,000) 1614 Ultraviolet-visible Reference Spectra JP XV
Neostigmine Methylsulfate
An aqueous solution (1 in 2000)
Nicardipine Hydrochloride
A solution in ethanol (99.5) (1 in 100,000)
Nicergoline
A solution in ethanol (99.5) (1 in 100,000) JP XV Ultraviolet-visible Reference Spectra 1615
Niceritrol
Asolutionin0.1mol/LhydrochloricacidTS(1in100,000)
Nicomol
Asolutionin1mol/LhydrochloricacidTS(1in100,000)
Nicotinamide
An aqueous solution (1 in 50,000) 1616 Ultraviolet-visible Reference Spectra JP XV
Nicotinic Acid
An aqueous solution (1 in 50,000)
Nifedipine
A solution in methanol (1 in 100,000)
Nilvadipine
A solution in ethanol (99.5) (1 in 100,000) JP XV Ultraviolet-visible Reference Spectra 1617
Nitrazepam
A solution in ethanol (99.5) (1 in 100,000)
Nitrendipine
A solution in methanol (1 in 80,000)
Noradrenaline
Asolutionin0.1mol/LhydrochloricacidTS(3in100,000) 1618 Ultraviolet-visible Reference Spectra JP XV
Norfloxacin
A solution in an aqueous solution of sodium hydroxide (1 in 250) (1 in 200,000)
Nortriptyline Hydrochloride
An aqueous solution (1 in 100,000)
Noscapine
A solution in methanol (1 in 20,000)